NCT05136807View on ClinicalTrials.gov

Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies

RecruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

June 7, 2016

Primary Completion Date

February 2, 2027

Study Completion Date

February 2, 2027

Conditions
Monoclonal Gammopathy of Undetermined SignificanceSmoldering Plasma Cell Myeloma
Interventions
OTHER

Quality-of-Life Assessment

Complete questionnaires

OTHER

Questionnaire Administration

Complete questionnaires

Trial Locations (1)

77030

RECRUITING

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER